1 |
R. Bataller, D. A. Brenner, “Liver fibrosis,” The Journal of Clinical Investigation, Vol. 115, No. 4, pp. 209-218, 2005.
DOI
|
2 |
S. C. Ong, S. G. Lim, S. C. Li. How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore, Journal of viral Hepatitis, Vol. 16, No. 1, pp. 53-63, 2009.
DOI
|
3 |
Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma, Clinical Liver Disease, Vol. 9, No. 2, pp. 191-211, 2005.
DOI
|
4 |
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors, Gastroenterology, Vol. 127, No. 5(suppl 1), pp. S35-50, 2004
DOI
|
5 |
Degos F, Christidis C, Ganne-Carrie N, Farmachidi JP, Degott C, Guettier C, et al. Hepatitis C virus related cirrhosis: Time to occurrence of hepatocellular carcinoma and death, Gut, Vol. 47, No. 1, pp. 131-136, 2000.
DOI
|
6 |
F. Piccinino, E. Sagnelli, G. Pasquale, G. Giusti, “Complications following percutaneous liver biopsy, A multicentre retrospective study on 68,276 bbipsies,” Journal of hepatology, Vol. 2, No. 2, pp. 85-87, 2016.
|
7 |
D. B. McGill, J. Rakela, A. R. Zinsmeister, B. J. Ott , “21-year experience with major hemorrhage after percutaneous liver biopsy,” The american journal of gastroenterology, Vol. 99, No. 5, pp. 1396-1400, 1990.
DOI
|
8 |
Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?, Journal of Hepatology, Vol. 50, No. 1, pp. 17-35, 2009.
DOI
|
9 |
E. S. Kim, Y. S. Seo, K. G. Lee et al, “The efficacy of measuring liver stiffness for the assessment of liver fibrosis in patients with chronic liver disease,” The Korean Association of internal Medicine, Vol. 74, No. 3, pp. 264-270, 2008.
|
10 |
P. Gines, A. Cardenas, V. Arroyo, J. Rodes, “Management of cirrhosis and ascites,” The New England Journal of Medicine, Vol. 350, No. 16, pp. 1646-1654, 2004.
DOI
|
11 |
Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?, Journal of Hepatology, Vol. 50, No. 1, pp. 17-35, 2009.
DOI
|
12 |
Nishiura T, Watanabe H, Ito M, Matsuoka Y, Yano K, Daikoku M, et al. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes, British Journal of Radiology, Vol. 78, No. 927, pp. 189-197, 2005.
DOI
|
13 |
Paggi S, Colli A, Fraquelli M, Vigano M, Del Poggio P, Facciotto C, et al. A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: A comparison using histology with internal-external validation. Journal of Hepatology, Vol. 49, No. 4, pp. 564-571, 2008.
DOI
|
14 |
H. S. Lee, J. K. Kim, J. Y. Cheong, E. J. Han, S. Y. An, J. H. Song, et al. Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis. The Korean Journal of Hepatology, Vol. 16, No. 4, pp. 369-375, 2010.
DOI
|